ARCHIVES

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

This article is from The Cancer Letter archive.

Vol. 31 No. 40 | November 4, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: New Mount Sinai Cancer Center Gets $7 Million; Jules Harris Named Rush Cancer Center Director

July 25, 1986

In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board

February 1, 1991

Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.

May 11, 2001

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

In Brief: NCI’s “Constant Dollar” Budget For FY 1979 Equal To 1975 Amount; Decosse Move to S-K

September 22, 1978